IP Library Granted Patent US 10,653,326
Granted Patent B2
US 10,653,326 · App. 15/505,696 · Granted May 19, 2020

Detection of patent ductus arteriosus using photoplethysmography

Inventors: Robert Koppel (West Hempstead, NY); Meir Nitzan (Bet El, IL)
Assignees: The Feinstein Institutes for Medical Research; Jerusalem College of Technology
A61B5/02416A61B5/02007A61B5/0452A61B5/6801A61B5/7282A61B5/0456A61B5/0472A61B5/6814A61B5/6825A61B5/6829A61B2503/04A61B2503/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,326
App. No.
15/505,696
Granted
May 19, 2020
Kind
B2
Abstract

Methods and systems are described for detecting the likelihood of patent ductus arteriosus (PDA) in an infant using electrocardiogram and photoplethysmographic pulse signals obtained from the upper body and foot of the infant.

Claims (29)

1. A system for detecting patent ductus arteriosus (PDA) in an infant comprising a photoplethysmograph having one or more channels, one or more computing devices comprising one or more processors, a memory unit, a display device, and a computer-readable storage medium including computer-readable code that is read by the one or more processors to perform a method comprising the steps of:

a) obtaining or receiving electrocardiogram (ECG) signals from the infant;

b) obtaining or receiving photoplethysmographic (PPG) signals from a site on the upper body (UB) of the infant, and optionally from a foot (F) of the infant;

c) determining, for each PPG pulse a PPG pulse amplitude (AM), the AM defined as an amplitude between the end-diastolic maximum and the consecutive systolic decrease minimum for the UB PPG pulses;

d) determining the mean of one or more of the following parameters for a plurality of the PPG pulses:

(i) a relative pulse amplitude (rAM) by dividing the AM by the systolic decrease minimum to obtain a rAM for the upper body (rAM-UB) PPG pulses;

(ii) a pulse transit time (PTT-UB) between an R wave of the ECG and an onset of systolic decrease for the corresponding UB PPG pulse;

(iii) a ratio PTT-UB/rAM-UB between the pulse transit time (PTT-UB) and the relative pulse amplitude for the UB (rAM-UB) PPG pulse; and

(iv) a ratio rAM-UB/PTT-UB between the relative pulse amplitude for the UB (rAM-UB) PPG pulse and the pulse transit time (PTT-UB); and

e) detecting patent ductus arteriosus (PDA) in the infant when one or more of:

the relative pulse amplitude for the UB (rAM-UB) is elevated above normal,

the ratio PTT-UB/rAM-UB is decreased below normal, or

the ratio rAM-UB/PTT-UB is elevated above normal,

wherein the term “normal” refers to values of parameters obtained from infants with a closed ductus arteriosus.

2. The system of claim 1 , wherein the steps further comprise one or more of selecting a section of PPG pulses without movement noise for analysis, low-pass filtering PPG signals to reduce high frequency noise, and smoothing PPG signals using a moving average filter.

3. The system of claim 1 , wherein the photoplethysmograph has an infrared light source.

4. The system of claim 1 , wherein in step d) a parameter from 10-20 pulses is averaged to obtain a mean.

5. The system of claim 1 , wherein UB PPG signals are obtained or received from the right hand of the infant.

6. The system of claim 1 , wherein UB PPG signals are obtained or received from the forehead or an earlobe of the infant.

7. The system of claim 1 , wherein a closed ductus arteriosus is detected when the rAM-UB value is 1.5% or less.

8. The system of claim 1 , wherein a patent ductus arteriosus (PDA) is detected when the rAM-UB value is above 2%.

9. The system of claim 1 , wherein a patent ductus arteriosus (PDA) is detected when the rAM-UB value is above a predetermined value in a range of 1.7% to 2.6%.

10. The system of claim 1 , wherein a closed ductus arteriosus is detected when the PTT-UB/rAM-UB ratio is 50 ms/% or more.

11. The system of claim 1 , wherein a patent ductus arteriosus (PDA) is detected when the PTT-UB/rAM-UB value is below 30 ms/%.

12. The system of claim 1 , wherein a patent ductus arteriosus (PDA) is detected when the PTT-UB/rAM-UB value is below a predetermined value in a range of 25 ms/% to 35 ms/%.

13. The system of claim 1 , wherein a closed ductus arteriosus is detected when the rAM-UB/PTT-UB ratio is 24%/s or less.

14. The system of claim 1 , wherein a patent ductus arteriosus (PDA) is detected when the rAM-UB/PTT-UB value is above 30%/s.

15. The system of claim 1 , wherein a patent ductus arteriosus (PDA) is detected when the rAM-UB/PTT-UB value is above a predetermined value in a range of 30%/s to 35%/s.

16. The system of claim 1 , further comprising obtaining or receiving echocardiographic measurements from the infant and using one or more of the following parameters in combination with rAM-UB or in place of rAM-UB: ratio left atrium diameter/aorta diameter, left pulmonary artery peak end diastolic velocity, and left ventricle shortening fraction.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE 2ND PROPERTY NUMBER PREVIOUSLY RECORDED AT REEL: 050188 FRAME: 0819-0826. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 10, 2020
From: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
To: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Reel/Frame 054372/0951 →
CHANGE OF NAME Recorded Aug 27, 2019
From: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
To: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Reel/Frame 050188/0819 →
Continuity (3)
Provisional Application 62042823 · Aug 28, 2014
Provisional Application 62134619 · Mar 18, 2015
Related Publication 20170273581A1 · Sep 28, 2017